Follow CGSP on Social Media

Listen to the CGSP Podcast

If/When Two Chinese COVID-19 Vaccines Get Approval From WHO, Demand From Developing Countries Likely to Increase

List of vaccines currently undergoing World Health Organization evaluation. Click to view larger image. Image via @BridgeBeijing.

Two Chinese-made COVID-19 vaccines made by Sinopharm and Sinovac are now under evaluation by the World Health Organization to receive the highly prized prequalification (PQ) status.

If the Chinese vaccines do receive WHO PQ certification, that could open up vast new markets in developing countries that rely on the global health body’s assessment before approving the use of certain pharmaceutical treatments.  Uganda, for example, has said that it will not import a Chinese vaccine unless it has been approved by the WHO.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Global South Project?


The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.